213 related articles for article (PubMed ID: 4165027)
1. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
Khazan N; Hirsch A; Sulman FG
Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
[No Abstract] [Full Text] [Related]
2. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
Wallach MB; Friedman E; Gershon S
J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
[No Abstract] [Full Text] [Related]
3. [Comparative study of the central effects of psychodysleptics in rabbits and cats].
Roche M
C R Seances Soc Biol Fil; 1970; 164(4):864-9. PubMed ID: 4252163
[No Abstract] [Full Text] [Related]
4. Studies on Withania ashwagandha Kaul. VI. The effect of the alkaloidal fractions (acetone, alcohol and water soluble) on the central nervous system.
Prasad S; Malhotra CL
Indian J Physiol Pharmacol; 1968 Oct; 12(4):175-81. PubMed ID: 5737360
[No Abstract] [Full Text] [Related]
5. An animal behavior model for decreased central serotonergic function.
Jacobs BL; Trulson ME
Adv Exp Med Biol; 1981; 133():657-80. PubMed ID: 7315613
[No Abstract] [Full Text] [Related]
6. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
Sloviter RS; Drust EG; Damiano BP; Connor JD
J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
[No Abstract] [Full Text] [Related]
7. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
Tonge SR; Leonard BE
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
[No Abstract] [Full Text] [Related]
8. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
Winter JC
J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
[No Abstract] [Full Text] [Related]
9. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
Dyer DC
J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
[No Abstract] [Full Text] [Related]
10. Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.
Aghajanian GK; Hailgler HJ
Psychopharmacol Commun; 1975; 1(6):619-29. PubMed ID: 1063421
[TBL] [Abstract][Full Text] [Related]
11. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
[No Abstract] [Full Text] [Related]
12. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
Otaka T
Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
[No Abstract] [Full Text] [Related]
13. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
Saavedra JM; Fischer E
Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
[No Abstract] [Full Text] [Related]
14. Participation of serotonin in development of morphine dependence in mice and rats.
Kruszewska A
Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
Marchbanks RM
Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
[No Abstract] [Full Text] [Related]
16. Indoleamines and the central nervous system; a sounding of their clinical significance.
van Praag HM
Psychiatr Neurol Neurochir; 1970; 73(1):9-36. PubMed ID: 4313906
[No Abstract] [Full Text] [Related]
17. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
18. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
Smythies JR; Beaton J; Benington F; Morin RD
Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
[No Abstract] [Full Text] [Related]
19. An electrographic study of d-lysergic acid diethylamide and nine congeners.
Schweigerdt AK; Stewart AH; Himwich HE
J Pharmacol Exp Ther; 1966 Mar; 151(3):353-9. PubMed ID: 5938474
[No Abstract] [Full Text] [Related]
20. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
